P669: Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response.
| Authors | |
|---|---|
| Year of publication | 2023 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Description | Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response - EHA 2023 in HemaSphere (2023) conference abstract. |
| Related projects: |